Arbutus Biopharma Q1 Exceeds Consensus View; Cuts Cash Burn Guidance
Arbutus Biopharma Corp (NASDAQ:ABUS) reported Q1 2023 revenues of $6.7 million, beating the consensus of $6.02 million. Revenues declined from…
Martin Marietta Materials Stock Jumps On Better Than Expected Q1 Results
Martin Marietta Materials, Inc. (NYSE:MLM) reported first-quarter FY23 revenue growth of 10% year-over-year to $1.35 billion, beating the consensus of $1.22…
Protalix Clocks 40% Decline In Q1 Revenues Reflecting Lower Sales To Brazil
Protalix BioTherapeutics, Inc. (AMEX:PLX) reported first-quarter FY23 total revenue of $9.59 million, down 40.4% year over year, on lower sales…
Why Ferrari Shares Are High On Racing Today
Ferrari NV (NYSE:RACE) reported first-quarter FY23 sales growth of 20.5% year-on-year to €1.42 billion. Total shipments of 3,567 units improved 9.7% from…
Why Upbound Shares Are Going Up Today
Upbound Group, Inc. (NASDAQ:UPBD) reported first-quarter FY23 revenues of $1.02 billion, beating the consensus of $994.16 million. Revenues fell 12.4%…
Why Intellia Therapeutics Shares Are Surging Today
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares are up Thursday as its Q1 results surpassed estimates. The company looks forward to sharing new interim data from NTLA-2001 and NTLA-2002 first-in-human studies in the coming months.
Why Gannett Shares Are Sliding Today
Gannett Co Inc (NYSE:GCI) reported a first-quarter FY23 sales decline of 10.6% year-on-year to $668.92 million, missing the consensus of…
Huntington Ingalls Beats On Q1, Reaffirms FY23 Expectations
Huntington Ingalls Industries Inc (NYSE:HII) reported a first-quarter FY23 sales and service revenue increase of 3.8% year-over-year to $2.672 billion, beating…
Parker-Hannifin Boosts FY23 Outlook Post Solid Q3 Beat As Demand Remained Strong
Parker-Hannifin Corp (NYSE:PH) reported third-quarter FY23 sales growth of 23.9% year-over-year to $5.06 billion and +12% on an organic basis, beating…
Royal Caribbean Cruises Breezes Past Q1 Expectations On Strong Bookings And Onboard Spend
Royal Caribbean Cruises Ltd (NYSE:RCL) reported first-quarter FY23 sales growth of 172.4% year-on-year to $2.88 billion, beating the consensus of $2.82…